Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

VFC's Stock House: Synergy Pharmaceuticals (SGYP) Ready To Roll

(EMAILWIRE.COM, May 22, 2012 ) New York, NY -- VFC's Stock House, an information and research outlet that brings ideas and opens discussions to a broad spectrum of investors, reported today that Synergy Pharmaceuticals (SGYP) may be in a position to realize significant share price gains over the coming months.



Synergy Pharmaceuticals (SGYP) ran to over seven dollars last month on increasing volume as the company's billion dollar potential took shape and numerous analysts jumped on board with encouraging write-ups and bold price predictions.



Synergy also received a boost when its chief competitor, Ironwood Pharmaceuticals (IRWD) received a setback at the FDA that allows SGYP an extra three months to play catch up in the race to commercialization for each company's respective product candidate, both of which target the same indication. Synergy's product Plecanatide, however, has a much more favorable side effect profile, making the Ironwood setback that much more of a key factor when discussing future market potential.



Both products, Synergy's Plecanatide and Ironwood's Linaclotide, are being developed to treat chronic idiopathic constipation (CIC) and constipation-predominant irritable bowel syndrome (IBS-C). Linaclotide is already before the FDA for review, although the review was delayed by three months, as mentioned before, while Phase II/III Plecanatide results are due out later this year.



The head start to market may provide Ironwood with a distinct advantage, but the advantage might not last too long when Plecanatide shows up on the scene.



During the Linaclotide trials, the drug was successful in alleviating symptoms relating to IBS-C and CIC when compared to a placebo, but the kicker is that patients experienced side effects that included cases of extreme diarrhea, essentially reversing the symptom being treated. Some cases of diarrhea were so bad that 6% of the patients decided to abandon the trial altogether.



On the open market - with a competing product out there for which there have been no such cases noted - that means those patients would likely switch to the alternative, in this case Plecanatide, that is not associated with carrying around a roll of Charmin' Soft at all times.



For full report visit: http://vfcsstockhouse.com/blog/article/-synergy-pharmaceuticals-sgyp-may-be-ready-to-roll



For full report and opinion visit: http://vfcsstockhouse.com/blog/article/-the-facebook-fb-ipo-don-t-believe-the-hype



Follow VFC's Stock House on Twitter: https://twitter.com/#!/VFCsStockHouse



'Like' VFC's Stock House on Facebook: http://www.facebook.com/pages/VFCs-Stock-House/143724412345213



About VFCsStockHouse.com:



VFC's Stock House is an information and research outlet that brings new ideas to the table and opens discussions for a broad spectrum of investors, with a strong focus on - but not limited to - biotech stocks and the pharmaceutical and healthcare sectors. VFC's Stock House provides individual company profiles, write-ups and reports as well as giving general insights into broader-market news through various 'Stock Watch' lists. At the conclusion of most weeks, VFC's Stock House issues a "Weekly Stock Watch" that examines news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well. The information contained within the pages of VFCs Stock House are not intended to be taken as advice, but as a starting point where investors can follow up with their own DD and devise their own entry and exit strategies.



For full disclaimer visit: http://vfcsstockhouse.com







VFC's Stock House
VFC
240-786-2111
vfc@vfcsstockhouse.com

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.


Spanish judge orders release of ill boy's parents
2 Sep 2014 at 11:30am

SOTO DEL REAL, Spain (AP) ? Spanish officials have ordered the immediate release of a detained British couple who were wanted by police in the United Kingdom after they took their critically ill child for treatment abroad without doctors' consent.


Cell transplant helps paralyzed man walk with frame
22 Oct 2014 at 4:21am
By Kate Kelland LONDON (Reuters) - (This October 20 story has been refiled to correct nationality of the patient to Polish after Nicholls charity corrected his details) A Polish man who was paralyzed from the chest down in a knife attack can now walk with the aid of a frame after receiving pioneering transplant treatment using cells from his nose. ...


U.S. government probes medical devices for possible cyber flaws
22 Oct 2014 at 4:11am

By Jim Finkle BOSTON (Reuters) - The U.S. Department of Homeland Security is investigating about two dozen cases of suspected cybersecurity flaws in medical devices and hospital equipment that officials fear could be exploited by hackers, a senior official at the agency told Reuters. ...



Beijing's focus on coal lost in haze of smog: experts
22 Oct 2014 at 4:11am

Beijing (AFP) - The soaring, grimy chimneys of the coal-fired power station have belched the last of their choking fumes into Beijing's air, authorities say -- but experts doubt the plan will ease the capital's smog.


Liberian air passenger checked for Ebola in New Jersey: media
22 Oct 2014 at 3:35am
(Reuters) - A Liberian passenger who flew into New Jersey on Tuesday was taken to hospital over fears he had been exposed to Ebola, media reported. The man, who had flown from Liberia to Brussels and then caught a connecting flight to Newark, had a fever, NBC New York reported, citing unnamed officials. The passenger was "identified as reporting symptoms or having a potential exposure to Ebola," a spokeswoman for the U.S. Centers for Disease Control and Prevention (CDC) told the network. The CDC was not immediately available for comment. ...

J&J, GSK ready to collaborate on Ebola vaccine work
22 Oct 2014 at 3:19am
LONDON (Reuters) - Drugmakers will work together to accelerate development of an Ebola vaccine and Johnson & Johnson and GlaxSmithKline, both of which have experimental vaccine candidates, have already discussed collaboration. J&J, which aims to have at least 1 million doses of its two-step vaccine available next year, said on Wednesday that vaccine makers would work together to maximize production of which ever vaccine proved successful in clinical trials. ...


Red Cross head says Ebola travel bans "irrational"
22 Oct 2014 at 2:52am

By Michael Martina BEIJING (Reuters) - Closing borders will not effectively curb Ebola infections, the head of the Red Cross said on Wednesday, amid debate over whether bans on travel from hardest-hit African countries would help combat the spread of the deadly virus. This year's outbreak of the highly infectious haemorrhagic fever thought to have originated in forest bats is the worst on record, having killed more than 4,500 people, mostly in Liberia, Guinea and Sierra Leone. Travellers from the region have infected two people in the U.S. ...



Florida candidates stake out political differences in third debate
22 Oct 2014 at 2:19am

By Bill Cotterell TALLAHASSEE Fla. (Reuters) - Florida Governor Rick Scott and former Governor Charlie Crist traded barbs on Tuesday over the minimum wage, the death penalty and racism in the Republican Party in the third and final debate of a close, bitterly contested race for governor. Polls show the two in an expensive, neck-and-neck race for the country's largest swing state, saturated in recent weeks by tens of millions of dollars of negative TV advertising. ...


Insurer ACE says excluding Ebola cover on some new and renewal policies
22 Oct 2014 at 2:09am
LONDON (Reuters) - U.S. insurer ACE said on Wednesday it was excluding cover for Ebola on some new and renewal policies. The company, which offers coverage for U.S.-based firms that travel or have operations outside the country, said it was selectively using a policy endorsement to exclude Ebola on a case-by-case basis for insureds that have foreign travel exposure to certain African countries. ...

J&J aims for 1 million Ebola vaccine doses in 2015
22 Oct 2014 at 1:50am
By Ben Hirschler LONDON (Reuters) - Johnson & Johnson is accelerating work on its experimental Ebola vaccine and aims to produce 1 million doses next year, 250,000 of which are expected to be available by May. There is currently no proven vaccine against the deadly disease but several companies are racing to develop products. Clinical tests on two - from GlaxoSmithKline and NewLink Genetics - are already under way. ...


Two cured in US, Spain, as Ebola crisis widens
22 Oct 2014 at 1:49am

Washington (AFP) - A US photojournalist has joined a Spanish nurse in being declared free of Ebola, as the United States tightened restrictions on travelers from the West African countries at the epicenter of the outbreak.



At least four months to contain Ebola: Red Cross chief
22 Oct 2014 at 1:43am

Beijing (AFP) - The Ebola epidemic will take at least four months to contain even if all necessary steps are taken, the global head of the Red Cross said Wednesday, warning of "the price for inaction".


French developer of 'peanut allergy patch' makes U.S. debut
22 Oct 2014 at 1:09am
By Nolle Mennella and Natalie Huet PARIS (Reuters) - French biotech firm DBV Technologies - developer of what it says is a breakthrough treatment for peanut allergy sufferers - makes its U.S. market debut on Wednesday, with a Nasdaq listing set to raise funds for further research. The Paris-listed company, which develops immunotherapy patches for patients with potentially fatal food allergies, is issuing 2.67 million new shares worldwide via a U.S. listing and a private placement which together will raise at least 90 million euros ($114 million). ...


Curfew in Sierra Leone town after rioting, shooting over Ebola case
22 Oct 2014 at 12:55am

FREETOWN (Reuters) - Authorities in Sierra Leone imposed a curfew in the eastern town of Koidu on Tuesday after a dispute between youth and police over a suspected case of Ebola degenerated into gunfire and rioting, officials said. A local civil society leader said he had seen at least two bodies with gunshot wounds. The head of the local police unit said youth had fired at officers with shotguns but denied anyone had been shot dead. The clashes highlight tensions in Sierra Leone over the government's attempt to bring the worst Ebola outbreak on record under control. ...


Red Cross official: 6 months to contain Ebola
22 Oct 2014 at 12:34am
BEIJING (AP) ? A top Red Cross official said Wednesday that he is confident the Ebola epidemic that has killed thousands of people in West Africa can be contained within four to six months.

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC